Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

• Last SEC data release: 2025-03-31
• Last 15 days FTD volume: €4.52 M
• Last 3 months FTD volume: €9.85 M
• Last year FTD volume: €9.85 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Arrowhead Pharmaceuticals ARWR	€3.01 M	€8.57 M	🇺🇸 USA
Regeneron Pharmaceuticals REGN	€23.26 M	€51.47 M	🇺🇸 USA
Sarepta Therapeutics SRPT	€0.8 M	€36.33 M	🇺🇸 USA
OPKO Health OPK	€5.41 M	€29.64 M	🇺🇸 USA
Regulus Therapeutics RGLS	€1.09 M	€5.43 M	🇺🇸 USA
Novartis NVS	€44.97 M	€0.15 B	🇨🇭 Switzerland
Sanofi SNY	€6.82 M	€53.35 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	€12.18 M	€42.24 M	🇮🇱 Israel